Comparing Imatinib vs Jakafi
| Imatinib Remove Imatinib from your drug comparison | Jakafi Remove Jakafi from your drug comparison |
|---|
| Imatinib Remove Imatinib from your drug comparison | Jakafi ruxolitinib Remove Jakafi from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Dermatofibrosarcoma Protuberans, Gastrointestinal Stromal Tumor, Hypereosinophilic Syndrome,... View more |
Prescribed for Myelofibrosis, Graft-versus-host disease, Polycythemia Vera, Myeloproliferative Disorders. Jakafi may also be used for purposes not listed in this medication guide. |
||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
See the full imatinib side effects document. |
Common side effects include: anemia, balance impairment, dizziness, headache, labyrinthitis, meniere's disease, neutropenia, thrombocytopenia, vertigo, and orthostatic dizziness. See the full Jakafi side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all imatinib prices |
View all Jakafi prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
Yes (this medicine) |
No |
||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
| Gleevec |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
40 hours |
5.8 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
A total of 622 drugs are known to interact with imatinib:
|
A total of 375 drugs are known to interact with Jakafi:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
|
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
|
April 18, 2003 |
November 16, 2011 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.